177
views
0
recommends
+1 Recommend
1 collections
    1
    shares
      scite_
       
      • Record: found
      • Abstract: found
      • Conference Proceedings: found
      Is Open Access

      Challenges and opportunities with multi-omics integration in precision medicine

      Published
      conference-abstract
      1
      REPO4EU
      RExPO23
      25-26 October 2023
      AI, machine learning, data science, bioinformatics, multi-omics, public data repurposing, data mining
      Bookmark

            Abstract

            In the era of personalized healthcare, precision medicine stands out as a transformative approach, offering bespoke therapeutic strategies tailored to individual patient molecular profiles. At the heart of this revolution lies multi-omics integration encompassing genomic, transcriptomic, proteomic, and metabolomic data which provides an intricate and comprehensive view of disease molecular underpinnings. Such integration not only fortifies diagnostic and prognostic accuracy but also enhances therapeutic interventions. This presentation will delve into both the challenges and the burgeoning potential of multi-omics in the sphere of precision medicine. We will also venture into the future, exploring the synergies of AI and multi-omics in propelling precision medicine and drug repurposing. A spotlight will be cast on Bio|Mx & Bio|Verse, pioneering solutions crafted to navigate and address contemporary challenges in this dynamic domain.

            Content

            Author and article information

            Conference
            REPO4EU
            9 October 2023
            Affiliations
            [1 ] BioLizard N.V.;
            Article
            10.58647/REXPO.23030
            3f78faf0-b756-4f1e-88da-21c5e038a300
            Authors

            Published under Creative Commons Attribution 4.0 International ( CC BY 4.0). Users are allowed to share (copy and redistribute the material in any medium or format) and adapt (remix, transform, and build upon the material for any purpose, even commercially), as long as the authors and the publisher are explicitly identified and properly acknowledged as the original source.

            RExPO23
            2
            Stockholm, Sweden
            25-26 October 2023
            History
            Product

            REPO4EU

            Categories

            Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
            Pharmacology & Pharmaceutical medicine
            AI,machine learning,data science,bioinformatics,multi-omics,public data repurposing,data mining

            Comments

            Comment on this article